Work

Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases

Year: 2017

Type: review

Study design: Systematic Review

Source: Value in Health

DOI: 10.1016/j.jval.2017.10.015

Authors: Michael Schlander, Charalabos-Markos Dintsios, Afschin Gandjour

Institutions: German Cancer Research Center, Heidelberg University, Heinrich Heine University Düsseldorf, Frankfurt School of Finance & Management

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: BioMarin Pharmaceutical

OpenAlex ID: W2769892380

FWCI: 1.516

Cites: 51

Cited by: 49

Related to: 10